| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 04/30/2009 | WO2009055734A1 Condensed compounds with activity at estrogen receptors |
| 04/30/2009 | WO2009054994A2 Use of compounds activating sirt-3 for mimicking exercise |
| 04/30/2009 | WO2009054483A1 Drug containing salusin-β |
| 04/30/2009 | WO2009054458A1 Composition for reducing the level of glucose, malondialdehyde-modified ldl, homocysteine and/or c-reactive protein in blood |
| 04/30/2009 | WO2009054128A1 Method for efficient production of monocyte-derived multipotent cell (momc) |
| 04/30/2009 | WO2009053895A2 Quinoline urotensin-ii receptor antagonists |
| 04/30/2009 | WO2009053748A2 Novel crystalline forms |
| 04/30/2009 | WO2009053716A1 Purine derivatives useful as pi3 kinase inhibitors |
| 04/30/2009 | WO2009053452A1 4,4-disubstituted piperidines |
| 04/30/2009 | WO2009053269A1 Novel kinase inhibitors |
| 04/30/2009 | WO2009052972A2 Use of norgestimate as a selective inhibitor of trpc3, trpc6 and trpc7 ion channels |
| 04/30/2009 | WO2009052630A1 Compositions and methods for treating fibroproliferative disorders |
| 04/30/2009 | WO2009033733A3 Use of apeptide as a therapeutic agent |
| 04/30/2009 | WO2009027077A8 5-arylalkylidene-2-arylalkyl-thiazol-4-one derivatives as inhibitors of 5-lipoxygenase and uses thereof |
| 04/30/2009 | WO2009010429A3 Novel heterocyclyl compounds and their use as chemokine antagonists |
| 04/30/2009 | WO2008134445A3 Platelet activation receptor clec-2: compositions and uses thereof |
| 04/30/2009 | WO2008102017A3 Food comprising polyunsaturated fatty acids for the prevention of chronic diseases |
| 04/30/2009 | WO2008046598A8 DERIVATIVES OF 4-(2-AMINO-1-HYDROXYETHYL)PHENOL AS AGONISTS OF THE β2 ADRENERGIC RECEPTOR |
| 04/30/2009 | WO2007059010A3 Stem cell factor therapy for tissue injury |
| 04/30/2009 | WO2004092199A3 Method for identifying modulators of g protein coupled receptor signaling |
| 04/30/2009 | US20090111859 2-(5,5-Dimethylcyclopent-1-enyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane; metabolic disorders such as type II diabetes |
| 04/30/2009 | US20090111840 Heterocyclic spiro-compounds as aldosterone synthase inhibitors |
| 04/30/2009 | US20090111826 Use of ranolazine for the treatment of cardiovascular diseases |
| 04/30/2009 | US20090111819 New pyridazin-3(2h)-one derivatives |
| 04/30/2009 | US20090111807 Novel 1,2,3,4-Tetrahydroquinoxaline Derivative Having Glucocorticoid Receptor Binding Activity |
| 04/30/2009 | US20090111806 Azaquinolone based compounds exhibiting prolyl hydroxylase Inhibitory activity, compositions, and uses thereof |
| 04/30/2009 | US20090111803 novel hydantoin derivatives to inhibit matrix metalloproteinases (MMPs), a disintegrin and metalloproteases (ADAMs) and/or tumor necrosis factor alpha converting enzyme (TACE) and in so doing prevent the release of tumor necrosis factor alpha (TNF- alpha ); autoimmune diseases; side effect reduction |
| 04/30/2009 | US20090111787 Polymer blends for drug delivery stent matrix with improved thermal stability |
| 04/30/2009 | US20090111778 2-Keto-Oxazoles as Modulators of Fatty Acid Amide Hydrolase |
| 04/30/2009 | US20090111777 Jelly Composition |
| 04/30/2009 | US20090110760 Lipometabolism improver containing pine bark extract |
| 04/30/2009 | US20090110755 Compositions and Methods for Preventing Migraines |
| 04/30/2009 | US20090110740 Materials and Methods for Modulating Metabolism |
| 04/30/2009 | US20090110711 Implantable device having a slow dissolving polymer |
| 04/30/2009 | US20090110709 Composition comprising an effective amount of a polyphenolic compound, in particular, ellagic acid and/or tannic acid, and a peptide for protection against degradation of cutaneous elastic fibers by elastolytic enzymes; for treating aging or damaged skin |
| 04/30/2009 | CA2704100A1 Compositions and methods for treating fibroproliferative disorders |
| 04/30/2009 | CA2703645A1 Composition for reducing the level of glucose, malondialdehyde-modified ldl, homocysteine and/or c-reactive protein in blood |
| 04/30/2009 | CA2703593A1 4,4-disubstituted piperidines |
| 04/30/2009 | CA2703230A1 Novel crystalline forms |
| 04/30/2009 | CA2703138A1 Purine derivatives useful as pi3 kinase inhibitors |
| 04/30/2009 | CA2702510A1 Use of norgestimate as a selective inhibitor of trpc3, trpc6 and trpc7 ion channels |
| 04/30/2009 | CA2701275A1 Novel kinase inhibitors |
| 04/30/2009 | CA2700210A1 Condensed compounds with activity at estrogen receptors |
| 04/29/2009 | EP2053409A1 Specific markers for metabolic syndrome |
| 04/29/2009 | EP2053403A2 Affinity fishing for ligands and proteins receptors |
| 04/29/2009 | EP2053042A1 Pyridine compounds for the treatment of prostaglandin mediated diseases |
| 04/29/2009 | EP2053041A2 1,3,5-Trisubstituted 2(1H)-pyridones as AMPA receptor inhibitors useful for the treatment of eg Parkinson's disease |
| 04/29/2009 | EP2052724A1 Use of norgestimate as a selective inhibitor of TRPC3, TRPC6 and TRPC6 and TRPC7 ion channel |
| 04/29/2009 | EP2052722A1 Methods for preventing or treating cardiac arrhythmia |
| 04/29/2009 | EP2051991A1 Cardioprotective compounds |
| 04/29/2009 | EP2051722A2 Method for treating diabetic vascular complications |
| 04/29/2009 | EP2051721A1 Preparation and pharmaceutical use of euterpe oleracea (acai) extract compositions |
| 04/29/2009 | EP2051717A1 Replacing heart surgery by micronutrient |
| 04/29/2009 | EP2051714A1 Drug combinations for the treatment of respiratory tract diseases |
| 04/29/2009 | EP2051712A2 Modulators of muscarinic receptors |
| 04/29/2009 | EP2051709A2 Phenylalkyl n-hydroxyureas for combating atherosclerotic plaque |
| 04/29/2009 | EP2051583A2 Compositions and methods for treating vascular, autoimmune, and inflammatory diseases |
| 04/29/2009 | EP1791813B1 Pentafluorosulfanylphenyl-substituted benzoylguanidines, method for the production thereof, their use as a medicament or diagnostic agent, and a medicament containing these compounds |
| 04/29/2009 | EP1734969A4 Novel anti-arrhythmic and heart failure drugs that target the leak in the ryanodine receptor (ryr2) and uses thereof |
| 04/29/2009 | EP1727555B1 Production of hop extracts having oestrogenic and antiproliferative bioactivity |
| 04/29/2009 | EP1720844B1 Pyrrolidino-1,2-dicarboxy-1-(phenylamide)-2-(4-(3-oxo-morpholino-4-yl)-phenylamide) derivatives and related compounds for use as inhibitors of coagulation factor xa in the treatment of thrombo-embolic diseases |
| 04/29/2009 | EP1687631B1 Methods for identifying compounds involved in the phosphoinositide-mediated signalling and use thereof in the manufacture of medicaments |
| 04/29/2009 | EP1601392B1 Compositions for use in embolizing blood vessels comprising high levels of contrast agent |
| 04/29/2009 | EP1485347B1 Hif hydroxylase inhibitors for use in the treatment of anaemia |
| 04/29/2009 | EP1454136B1 Methods and means for influencing intracellular communication and intracellular organelle transport |
| 04/29/2009 | EP1446379B1 Aryl aniline beta-2 adrenergic receptor agonists |
| 04/29/2009 | EP1446125B1 Thieno-(1,3)-oxazin-4-ones with lipase inhibiting activity |
| 04/29/2009 | EP1438288B1 Substituted thioacetamides |
| 04/29/2009 | EP1416937B1 Prophylactic and therapeutic use of hydroxysteroids |
| 04/29/2009 | EP1296652B1 Topical pharmaceutical formulations and methods of treatment |
| 04/29/2009 | EP1267914B1 Use of lysosomal acid lipase for treating atherosclerosis and related diseases |
| 04/29/2009 | EP1257582B1 Method for inhibiting angiogenesis using molecules that enhance plasmin formation or prolong plasmin activity |
| 04/29/2009 | EP1218509B1 Fibroblast growth factor-like polypeptides |
| 04/29/2009 | EP1066286B1 Heterocyclo-substituted imidazopyrazine protein tyrosine kinase inhibitors |
| 04/29/2009 | CN201227079Y Far infrared cassia seed pillow |
| 04/29/2009 | CN101421278A Condensed imidazole derivatives as aldosterone synthase inhibitors |
| 04/29/2009 | CN101421231A Salt of aliskiren with sulfuric acid |
| 04/29/2009 | CN101420980A Compounds and methods for treatment of stroke |
| 04/29/2009 | CN101420979A Method of treatment of myocardial infarction |
| 04/29/2009 | CN101420969A Agent for preventing arteriosclerosis, agent for suppressing vascular intimal thickening and agent for improving vascular endothelial function |
| 04/29/2009 | CN101420968A Vasodilator |
| 04/29/2009 | CN101420960A Method for treating aortic stenosis with non-antibacterial tetracycline formulations |
| 04/29/2009 | CN101418329A Preparation method of rapeseed proteolysis peptides based on pulse ultrasonic technology and use thereof |
| 04/29/2009 | CN101417971A Indolines compounds, preparation method and pharmaceutical application thereof |
| 04/29/2009 | CN101417964A Use of compounds for the elevation of pyruvate dehydrogenase activity |
| 04/29/2009 | CN101417152A Local vascular delivery of mtor inhibitors in combination with peroxisome proliferators-activated receptor stimulators |
| 04/29/2009 | CN101417129A Gabapentin analogues for fibromyalgia and other related disorders |
| 04/29/2009 | CN101417114A Traditional Chinese medicine for treating hypertension and high blood-fat |
| 04/29/2009 | CN101417093A Traditional Chinese medicine preparation for treating dizziness |
| 04/29/2009 | CN101417092A Traditional Chinese medicine plaster for treating hypertension |
| 04/29/2009 | CN101417086A Traditional Chinese medicine preparation for treating myocardial ischemia |
| 04/29/2009 | CN101417082A Traditional Chinese medicine combination for treating rheumatic heart disease |
| 04/29/2009 | CN101417080A Traditional Chinese medicine preparation for treating rheumatic heart disease |
| 04/29/2009 | CN101417074A Medicine for treating coronary disease |
| 04/29/2009 | CN101417057A Traditional Chinese medicine decoction for treating rheumatic heart disease |
| 04/29/2009 | CN101417047A Internal hemorrhoid dispersion medicine |
| 04/29/2009 | CN101417042A Medical composition capable of treating hypertension |
| 04/29/2009 | CN101417041A Traditional Chinese medicine preparation capable of preventing and treating coronary heart disease angina, heat-stroke abdomen pain, heart and abdomen pain |
| 04/29/2009 | CN101417005A Gentian bitterness concealing technique in oral liquid |
| 04/29/2009 | CN101416999A Traditional Chinese medicine formulation for treating cerebrovascular disease |